XML 35 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jan. 29, 2022   29,612,867        
Beginning balance, value at Jan. 29, 2022 $ 758,544 $ 9,871 $ 2,028 $ (1,769) $ 748,414  
Increase (Decrease) in Stockholders' Equity            
Stock options exercised (in shares)   119,430        
Stock options exercised 4,557 $ 40 4,517      
Stock-based compensation (in shares)   1,824        
Stock-based compensation 17,927 $ 1 17,926      
Issuance of restricted stock, net of tax withholdings (in shares)   129,930        
Issuance of restricted stock, net of tax withholdings (5,752) $ 43 (3,449)   (2,346)  
Repurchase of common stock (in shares)   (514,030)        
Repurchase of common stock (48,732) $ (172) (15,368)   (33,192)  
Other comprehensive income (loss)       (2)    
Net income 142,213         $ 142,213
Ending balance, value at Jan. 28, 2023 868,755 $ 9,783 5,654 (1,771) 855,089  
Ending balance (in shares) at Jan. 28, 2023   29,350,021        
Increase (Decrease) in Stockholders' Equity            
Stock options exercised (in shares)   19,736        
Stock options exercised 1,149 $ 7 1,142      
Stock-based compensation (in shares)   1,759        
Stock-based compensation 25,457 $ 1 25,456      
Issuance of restricted stock, net of tax withholdings (in shares)   204,762        
Issuance of restricted stock, net of tax withholdings (9,903) $ 68 (6,072)   (3,899)  
Repurchase of common stock (in shares)   (485,000)        
Repurchase of common stock (49,949) $ (162) (19,963)   (29,824)  
Other comprehensive income (loss) 224     224    
Net income 218,923       218,923  
Ending balance, value at Jan. 27, 2024 $ 1,054,656 $ 9,697 6,217 (1,547) 1,040,289  
Ending balance (in shares) at Jan. 27, 2024 29,091,278 29,091,278        
Increase (Decrease) in Stockholders' Equity            
Stock options exercised (in shares)   74,669        
Stock options exercised $ (7,959) $ 25 (7,984)      
Stock-based compensation (in shares)   1,075        
Stock-based compensation 40,320   40,320      
Issuance of restricted stock, net of tax withholdings (in shares)   221,927        
Issuance of restricted stock, net of tax withholdings (17,044) $ 74 (6,815)   (10,303)  
Repurchase of common stock (in shares)   (410,000)        
Repurchase of common stock (65,836) $ (137) (22,747)   (42,952)  
Other comprehensive income (loss) 1,547     1,547    
Net income 233,413       233,413  
Ending balance, value at Jan. 25, 2025 $ 1,239,097 $ 9,659 $ 8,991 $ 0 $ 1,220,447  
Ending balance (in shares) at Jan. 25, 2025 28,978,949 28,978,949